Osteoarthritis is a slowly progressive disease which includes the intervention of several cytokines and macrophage metalleinoproteinases reaction, leading to the degradation of the local cartilage but also having an impact on the serum acute phase proteins (APPs). Subsequently, biomarkers seem to be essential to estimate its progression and the need for any surgical intervention such as total arthroplasty, but also can be used as therapeutic agents. Recently, among APPs, fetuin-A drew attention regarding its possible anti-inflammatory role in animal models but also as a therapeutic agent in the inflammatory joint disease in clinical trials. The purpose of this study is to investigate the possible attenuating role of the intra-articular administration of Fetuin-A in post-traumatic induced secondary osteoarthritis in rats, and also its effect on the systematic levels of IL-2,4,7, BMPs 2,4,7, CRP and Fetuin-A.

30 male Sprague Dawley rats were separated in two groups where post-traumatic osteoarthritis was induced surgically by Anterior Cruciate Ligament Transection and the transection of the Medial Collateral Ligament of the right knee. In the Control Group, only surgical intervention took place. In Fetuin Group, along with the induction of osteoarthritis, a single dose of bovine fetuin was administrated intra-articularly intra-operatively in 5 and 8 weeks of the experimental protocol. Both groups were examined for 8 weeks. The levels of interleukins, bone morphogenetic proteins, Fetuin-A and C-Reactive Protein were evaluated by ELISA of peripheral blood in three time periods: preoperatively, 5 and 8 weeks post-operatively. Knee osteoarthritic lesions were classified according to Osteoarthritis Research Society International Grading System and Modified Mankin Score, by histologic examination.

IL-2 levels were significantly decreased in the Fetuin Group. No statistical difference was signed on the levels of IL-7, BMP-2,4,7 and Fetuin-A between the two groups. CRP levels were significantly increased in the Fetuin Group in 5 weeks of the experiment. Fetuin Group signed better scores according to the OARSI classification system and Modified Mankin Score, without any statistical significance.

Intra-articular administration of Fetuin-A restrictively affected the progression of post-traumatic arthritis in rats, as only the levels of IL-2 were decreased as well as limited osteoarthritic lesions were observed on the Fetuin Group.

Background and Objectives: It has been extensively discussed that there is a lowering effect of Replacement Therapy on lipids and lipoproteins. Recent hypotheses relate the lipids and osteoporosis. Thus, there is a possibility that hormone therapy improves osteoporosis not only via direct effect of estrogens on bone tissue, but also via lowering the lipids that may have detrimental effect on bone tissue. The aim of this study was to assess the effect of various regimens of hormone therapy on lipids and osteoporosis and the correlation between lipids and osteoporosis under given hormone treatment.

Methods: Three hundred and thirty five women (n=335) participated in this open study and were assigned to receive orally (a) CEE (n=29), (b) Tibolone (n=75), (c) CEE/MPA (n=57), (d) E2/NETA (n=72), (e) raloxifene (n=64) and (f) no therapy (control) (n=68) for at least 12 months. At baseline and 12 months blood samples were taken and analyzed for lipids and lipoproteins (total cholesterol, triglycerides, HDL, LDL, Lipoprotein (a), Apolipoprotein-A1, Apolipoprotein–B). At baseline and 12 months DEXA was also performed for the measurement of BMD of the lumbar spine.

Results: In the unopposed estrogen group (CEE) most of the variables were negatively connected with osteoporosis and BMD, but none of them were statistically significant. In the raloxifene group similar features were observed, but only LDL reached statistical significance (p=0.0031). In the tibolone group almost all variables were negatively correlated with osteoporosis and BMD, but again only LDL reached statistical significance (p=0.038). In the E2/NETA group most variables were negatively correlated with osteoporosis and BMD, but none reached statistical significance. In the CEE/MPA group all of the variables were negatively correlated with BMD and osteoporosis, but statistical significance was reached by total cholesterol, LDL and Lp(a) (p=0.008, 0.007, 0.047 respectively).

Conclusion: In this study it has been observed that there is a trend in almost every medication group towards an inverse correlation between lipids and BMD. The effect is more prominent in the tibolone, raloxifene and, mainly, in the CEE/MPA group. The greater effect was observed from the point of the lipids, in the LDL variable group. It is very important to clarify whether these findings could be extrapolated at orthopaedic trauma research providing thus a novel explanation for the aetiology of atrophic non unions in patients with compromised vascular function either locally or systematically.

Purpose: Athrophic non unions constitute a major problem in orthopaedic trauma. The main probably cause of atrophic non union is damage of the vascular system and dysfunctional regeneration of the vasculature at the area of the fracture. The most important hormonal pathway controlling angiogenesis is VEGF (Vascular Endothelial Growth Factor). The use of VEGF for enhancing bone healing in atrophic non unions could be a very promising solution for the future. An interesting alternative to the use of VEGF is the use of Erythropoietin (Epo). VEGF has been also reported to interact with Endothelial Progenitor Cells (EPCs). Our scope is to identify a possible new role for Epo as a valid substitute for VEGF through the clarification of the molecular and cellular pathways of fracture healing.

Methods: A survey was conducted via internet (Med-line - Pubmed, Cochrane database, Scopus) and relevant textbooks.

Results: It has been reported that Epo could induce increased chemotaxis, migration of Mesenchymal Stem Cells (MSCs), but also activation of Metaloproteinase - 9 and production of pro-angiogenic factors. These effects on MSCs could explain the observation that Epo could be very useful in the treatment of wound healing and burn healing in animal studies. It has been that Epo could express receptors at the chondrocytes, but also induce better bio-mechanical strength, callus formation, histomophometric image and increased bone density at the treated with Epo animals when compared with control animals. It is also worthy to note that the Epo has been found to stimulate neo-vascularisation in vivo, differentiation of endothelial cell lines towards a vascular pathway and improvement of cardiac function through EPCs and VEGF, implying Epo also in the differentiation and chemotaxis of the circulating EPCs. We should not forget that the transformation of EPCs in mesenchymal cells (i. g. myoblasts) has already been demonstrated.

Conclusions: The consequences of these observations could be very interesting: EPCs have been reported to enhance neo-vascularisation and angiogenesis at the region of the fracture. All these imply a novel role for EPCs in combination (or even replacing the rare) MSCs under the influence of VEGF and Epo for the enhancement of fracture vascularisation and healing enhancement. Further studies should clarify this new field in basic orthopaedic, trauma and bone metabolism science.

Purpose: The objective of this study was to compare the results of a single mini-incision posterior approach with those of a standard posterior incision total hip arthroplasty.

Patients & methods: During the year 2005 52 patients were randomized to undergo total hip arthroplasty (THA) surgery through a short incision of 10 cm (or less) or a standard incision of 16 cm. 27 pts (20 females – 7 males) underwent THA through a posterior standard approach whereas 25 pts (19 females – 6 males) underwent THA through a posterior minimal invasive technique. Surgical indication was primary degenerative osteoarthritis in all patients. A single experienced surgeon performed all operations. In all patients the same cementless acetabulum and femoral component was used. The anaesthetic, analgesic, and postoperative physiotherapy protocols were standardized in both groups. The patients were compared with respect to the preoperative ASA score, incision length, hospital stay, intraoperative blood loss, postoperative blood transfusion, early mobilisation and satisfaction evaluated by the Harris Hip Score(HHS) and the visual analoque scale (VAS) for pain.

Results: The two groups were matched for age, grade according to the system of the American Society of Anesthesiologists and the preoperative Harris Hip Score. No significant difference was detected with respect to average surgical time, postoperative hematocrit, blood transfusion requirements, pain scores, or analgesic use. Additionally, we found no difference in early walking ability or length of hospital stay and no difference in component placement or functional outcome scores at the latest follow-up 6 – 12 months (mean 8 months) after surgery.

Conclusions: In arthroplasty the term ‘minimal invasive’ not only refers to the length of the skin incision but more so to its soft tissue protecting features and thereby to a better outcome. There was no evidence that the mini-incision technique resulted in less bleeding or less trauma to the soft tissues of the hip. Even more, it offers no significant benefit in the early postoperative or late period compared with a standard incision of 16 cm.

Background: Misplaced pedicle screws are associated with significant complications during posterior spinal instrumentation.

Purpose: The purpose of this study is to evaluate the efficacy of triggered electromyographic stimulation in predicting the appropriate placement of pedicle screws.

Study Design: Prospective clinical trial.

Patient Sample: Fifteen consecutive patients (3 males; 12 females).

Outcome Measures: Not applicable.

Materials and Methods: All patients underwent posterior thoracolumbar spine fusion. Surgery was performed for spondylolisthesis, spinal stenosis, degenerative scoliosis and fractures. All patients received continuous electromyographic monitoring during surgery. During insertion of pedicle screws the integrity of the medial pedicle cortex was tested by stimulating each screw head with a monopolar pedicle probe stimulator and recording the compound muscle action potentials. A threshold of 7 mA and below was considered indicative of pedicle breach. Intraoperative screw placement was verified with the use of image intensifier. Finally, all patients following surgery underwent plain radiographs and CT scan of the operated region to evaluate the position of the pedicle screws.

Results: One hundred and fourteen pedicle screws were inserted from T7 to S1 in all patients. There were no myogenic responses at the threshold tested. No screw had to be repositioned intraoperatively. There were no new neurologic deficits recorded following surgery. Review of the radiographs and CT scans obtained following surgery revealed no medial pedicle cortex breach. There were two screws that violated the lateral pedicle cortex, without any subsequent complications for the patients.

Conclusions: Our study suggests that the absence of myogenic responses following stimulation at a threshold of 7 mA and below during pedicle screw placement, is a strong indicator that no medial pedicle cortex breach has occurred.

Introduction: Minimally invasive augmentation techniques of vertebral bodies have been widely used in the treatment of painful osteoporotic vertebral compression fractures (VBCFs). Kyphoplasty seems to achieve pain relief and improvement in quality of life. However, the effect of kyphoplasty on the height and the kyphotic deformity of the vertebrae is now yet clear. The present study reports our experience in kyphoplasty procedures for osteoporotic VBCF’s.

Materials and Methods: A total of 105 VBCF (45 thoracic and 60 lumbar vertebrae) in 56 patients (16 male, 40 female; mean age: 69 years, range 32–87 years) were treated with kyphoplasty between 2002–2005. All patients were preoperatively evaluated with radiographs, MRI and bone scintigraphy, and postoperatively immediately following the procedure and 6 months later with radiographs. Eight patients were treated within a week from their injury (new fractures). All patients completed the Oswestry Disability Index Questionnaire pre- and immediately post-operatively and at 6 months. The height of the treated vertebrae and the kyphotic deformity were measured before, after the kyphoplasty and at 6 months. All procedures were performed under general anaesthesia and fluoroscopy guidance.

Results: 54 patients were included in the study; 2 patients expired from causes unrelated to the procedure. All patients experienced pain relief following the procedure and the average Oswestry Disability Index score decreased from 76% preoperatively to 12.4% postoperatively (P< 0.001) and to 18.5% (P< 0.001) at 6 months. The observed mean height restoration at 6 months was 3mm (range 0–15mm) (P=NS) and the kyphotic deformity correction was 3.70 (0–120) (P=NS). In the new fractures the height restoration was 7.1mm and the kyphotic correction 7.80 (P=0.01). There were no cases of pulmonary embolism nor were any significant cement leakages noted.

Conclusion: The treatment of painful osteoporotic VBCFs with kyphoplasty is safe and reduces pain and disability. However, it does not lead to restoration of the vertebral height nor to correction of the kyphotic deformity, except in new fractures.

Aim: To evaluate the feasibility of Norian S.R.S in the treatment of comminuted distal radius fractures.

Material and methods: 24 patients with comminuted distal radius fractures were open reduced and preserved with external fixation. The bone gaps were filled with Norian S.R.S. The wrist was mobilized at the 3rd postoperative week and the external fixation was removed the 4th–6th postoperative week, when the fracture healing was radiologically confirmed. All the patients had regular clinical and radiological control the first postoperative date and the 1rd, 3rd, 4th postoperative week and monthly until the 9th postoperative month.

Results: In the postoperative follow-up we didn’t note any loss of reduction and the joint range of motion compared with the contralateral exceeded 50% in 3 months and came close to 85% in 6 months. There were no clinically significant adverse effects or complications.

Conclusions: We believe that the use of Norian S.R.S. offers the potential for filling bony voids, does not exhibit tissue reactions and is progressively absorbed. The results of this study are comparable with other therapeutic approaches. Additionally, the use of the Norian S.R.S offers the potential of earlier mobilization and as an implant is bioabsobable through osteoclastic activity. In conclusion we believe that use of Norian S.R.S in the filling of bony defects in the comminuted distal radius fractures is a reliable and safe method of treatment.